Am J Kidney Dis. 1997 Aug;30(2 Suppl 1):S40-53.
The number of patients starting ESRD therapy continues to increase, although this report shows evidence that the incidence rates are growing at a slower pace than they did in earlier years. The number of patients undergoing ESRD therapy also continues to increase, but the rate of increase is down to 7% from 9% to 10%. There is some uncertainty in these estimates in part because the reporting of non-Medicare patients has changed.
开始接受终末期肾病(ESRD)治疗的患者数量持续增加,尽管本报告显示有证据表明发病率的增长速度比前些年有所放缓。接受ESRD治疗的患者数量也持续增加,但增长率已从9%至10%降至7%。这些估计存在一定不确定性,部分原因是未参加医疗保险患者的报告方式发生了变化。